Advertisement

Topics

FDA Approves PDUFA Fee Waiver for Gimoti New Drug Application

17:03 EST 5 Mar 2018 | Drugs.com

SOLANA BEACH, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) d­­iseases, today announced that the U.S. Food and Drug Administration...

Original Article: FDA Approves PDUFA Fee Waiver for Gimoti New Drug Application

NEXT ARTICLE

More From BioPortfolio on "FDA Approves PDUFA Fee Waiver for Gimoti New Drug Application"

Advertisement
Quick Search
Advertisement
Advertisement